FDA approves first new Alzheimer’s disease drug in nearly 20 years
(CNN) – In a controversial decision, the US Food and Drug Administration approved the use of an experimental drug used for early phases of Alzheimer’s disease Monday.
The drug aducanumab was approved despite an FDA advisory committee concluding last year that there is not enough evidence to support the effectiveness of the treatment, CNN reports.
The drug was developed for patients with mild cognitive impairment, not severe dementia, and intended to slow progression of Alzheimer’s disease — not just ease symptoms.
The FDA has not approved a novel therapy for Alzheimer’s...